The store will not work correctly when cookies are disabled.
7-{[3-(4-Flourophenyl)-4,5-dihydro-1,2-oxazol-5-yl]methoxy}-4-methyl-2H-chromen-2-one
ID: ALA4758100
PubChem CID: 162656376
Max Phase: Preclinical
Molecular Formula: C20H16FNO4
Molecular Weight: 353.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(=O)oc2cc(OCC3CC(c4ccc(F)cc4)=NO3)ccc12
Standard InChI: InChI=1S/C20H16FNO4/c1-12-8-20(23)25-19-10-15(6-7-17(12)19)24-11-16-9-18(22-26-16)13-2-4-14(21)5-3-13/h2-8,10,16H,9,11H2,1H3
Standard InChI Key: SVFCEWYPNXBHSW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
35.8601 -19.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8589 -20.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5670 -21.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5652 -19.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2738 -19.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2746 -20.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9831 -21.2147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6914 -20.8039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6866 -19.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9775 -19.5784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9732 -18.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4006 -21.2098 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1509 -21.2198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4435 -20.8107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7355 -21.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9926 -20.8880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4453 -21.4949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8534 -22.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6528 -22.0336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6358 -21.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3048 -20.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4929 -20.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0112 -21.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3471 -21.9845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1580 -22.0673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1984 -21.1500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
8 12 2 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
17 20 1 0
23 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.35 | Molecular Weight (Monoisotopic): 353.1063 | AlogP: 3.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 61.03 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.24 | CX LogP: 3.81 | CX LogD: 3.81 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.67 | Np Likeness Score: -0.80 |
References
1. Lingaraju GS,Balaji KS,Jayarama S,Anil SM,Kiran KR,Sadashiva MP. (2018) Synthesis of new coumarin tethered isoxazolines as potential anticancer agents., 28 (23-24): [PMID:30396758] [10.1016/j.bmcl.2018.10.046] |